Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the world's most lethal diseases.
Ten63 Therapeutics's investors include Draper Associates, SOSV, Hatteras Venture Partners, IndieBio, Alexandria Venture Investments.
Ten63 Therapeutics is headquartered in Durham, United States.
Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the world's most lethal diseases.
Ten63 Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ten63 Therapeutics — Funding & Investors." VCBacked, December 19, 2024, https://www.vcbacked.co/company/ten63-therapeutics. Accessed September 3, 2026.
VCBacked. (2024). Ten63 Therapeutics — Funding & Investors. Retrieved September 3, 2026, from https://www.vcbacked.co/company/ten63-therapeutics
{{cite web |title=Ten63 Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/ten63-therapeutics |website=VCBacked |access-date=September 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated